Yahoo
NasdaqCM - Delayed Quote USD

Entera Bio Ltd. (ENTX)

1.2400 -0.0300 (-2.36%)
At close: May 20 at 4:00:01 PM EDT
Chart Range Bar
Loading chart for ENTX
  • Previous Close 1.2700
  • Open 1.2700
  • Bid 1.2300 x 100
  • Ask 1.2800 x 100
  • Day's Range 1.2200 - 1.2700
  • 52 Week Range 0.9100 - 3.2200
  • Volume 23,492
  • Avg. Volume 167,706
  • Market Cap (intraday) 61.039M
  • Beta (5Y Monthly) 1.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2600
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.00

Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It develops EB613, an oral teriparatide, which completed the Phase II clinical trial for the treatment of osteoporosis and Phase I clinical trial for the treatment of stress fractures. The company is also involved in the development of EB612, a tablet peptide replacement therapy, which is in Phase I clinical trial for the treatment of hypoparathyroidism; EB618, a GLP-1/glucagon dual agonist peptide, which is in Phase I clinical trial for the treatment of obesity, metabolic, and fibrotic disorders; and GLP-2 which is in Phase I clinical trial for the treatment of short bowel syndrome and disorders related to mucosal inflammation and nutrient malabsorption. It has a collaboration agreement with OPKO Biologics, Inc for the preclinical and clinical development of LA-PTH and oral dual agonist GLP-1/glucagon peptide. The company was incorporated in 2009 and is based in Jerusalem, Israel.

enterabio.com

20

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview: ENTX

Trailing total returns as of 5/20/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ENTX
36.08%
S&P 500 (^GSPC)
8.58%

1-Year Return

ENTX
39.81%
S&P 500 (^GSPC)
25.12%

3-Year Return

ENTX
33.76%
S&P 500 (^GSPC)
77.31%

5-Year Return

ENTX
59.34%
S&P 500 (^GSPC)
78.71%

Earnings Trends: ENTX

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings --

Q4

FY24

Q3

FY25

Q4

FY25

Q1

FY26

0
20K
40K
60K
80K

Analyst Insights: ENTX

View More

Analyst Price Targets

9.00
9.00 Average
1.2400 Current
9.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/27/2026
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 10 -> 9

Statistics: ENTX

View More

Valuation Measures

Annual
As of 5/20/2026
  • Market Cap

    60.79M

  • Enterprise Value

    57.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.43k

  • Price/Book (mrq)

    5.69

  • Enterprise Value/Revenue

    1.53k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -45.01%

  • Return on Equity (ttm)

    -82.33%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -12.38M

  • Diluted EPS (ttm)

    -0.2600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.14M

  • Total Debt/Equity (mrq)

    4.19%

  • Levered Free Cash Flow (ttm)

    -4.84M

Compare To: ENTX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: ENTX

Fair Value

1.2400 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: ENTX

View More
  • Daily – Vickers Top Insider Picks for 05/08/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 05/07/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 05/06/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 05/05/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: